Starting on:
Oct 23, 2020
Ending on:
Oct 23, 2020
Moderator(s):
Venue:
Webinar
Max Credits:
3 Points
Provider:
Heart and Life Conferences
Claim Points
Oct 23, 2020
Ending on:
Oct 23, 2020
Moderator(s):
Webinar
Max Credits:
3 Points
Provider:
Heart and Life Conferences
Claim Points
Current Utility of DPP-4 Inhibitors.
Starting on:
Oct 23, 2020 7:00 PM
Oct 23, 2020 7:00 PM
Ending on:
Oct 23, 2020 9:00 PM
Oct 23, 2020 9:00 PM
Venue:
Webinar
Webinar
Description
Current Utility of DPP-4 Inhibitors.
Objectives
Current utility of DPP- 4 Inhibitors are important oral antidiabetic agents that are placed as second-line therapy after metformin failure as insulinotropic agents that have no intrinsic hypoglycaemia risk and are body weight neutral.
Presenters
-
Dr.
Erick Njenga
Diabetologist
-
Dr.
Nancy Kunyiha
Endocrinologist
-
Dr.
Mohamed Sood
Nephrologist
-
Dr.
Hellen Nguchu
Cardiologist
-
Dr.
Sairabanu Sokwala
Endocrinologist